A Preston woman, diagnosed with ovarian cancer when her first grandchild was only nine days old, shared how she felt guilty ...

INX-315, a CDK2 inhibitor, gained FDA fast track status in CCNE1-positive platinum-resistant/refractory ovarian cancer.

Individuals who transition from overweight to obese during adulthood may face a higher ovarian cancer risk, highlighting the ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

It was also associated with an increased risk of dying from cancer, most notably with ovarian and breast cancers. For every ...

There has been a surge in the number of younger people receiving cancer diagnoses – and scientists are beginning to ...